Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teduglutide for acute myocardial infarction
ChiCTR2500095623Phase 2Recruiting
- Sponsor
- The First Affiliated Hospital, Anhui Medical University
- Start
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial in myocardial infarction (MI) comparing Placebo control with Teduglutide (2 arms). Primary endpoints: Infarct size and Microvascular obstruction volume. Started Jan 2025; status: recruiting.
02
Drugs
teduglutide
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR2500095623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095623.